Internet and Psychiatry
  • Home
    • Editorials
    • Research news
    • Research papers
    • Interviews with eminent psychiatrists
    • Ten years ago
    • Fifteen years ago
  • Topics
    • Alcohol and Drug Abuse
    • Anxiety Disorders
    • Biomedical Science
    • Compulsive gambling
    • Disaster Medicine
    • Education
    • General Medicine
      • Acupuncture
      • Physical medicine and Rehabilitation
    • Human Rights
    • Interviews with eminent psychiatrists
    • Mood Disorders
      • Bipolar Disorder
      • Depression
      • Seasonal Affective Disorder
    • Neurological Disorders
    • Other Psychiatric Disorders
    • Posttraumatic Stress Disorder
    • Sexual Behavior
  • Books
    • Comorbidity of Depression and Alcohol Use Disorders
    • “Immigration and Mental Health” chapter abstracts
    • “Internet and Suicide” chapter abstracts
    • “Neurobiology of PTSD” chapter abstracts
    • “Suicidal Behavior in Alcohol…” chapter abstracts
    • “Suicide in the Military” chapter abstracts
    • “Terror and Suicide” chapter abstracts
    • “War and Suicide” chapter abstracts
  • Editors
    • Leo Sher, M.D.
    • Alexander Vilens, M.S.
  • Guests
    • Distinguished Guests
    • Our Contributors
  • Reflections
    • Poetry
    • Quotes

Research news

COVID-19 prevalence and mortality among patients with schizophrenia

March 15, 2021

Leo Sher, M.D.

A research report, “COVID-19 prevalence and mortality among schizophrenia patients: A large-scale retrospective cohort study” has been published in Schizophrenia Bulletin online ahead of print (1). The authors aimed to address the following research questions: (1) Are patients with schizophrenia more prone to COVID-19 infections? and (2) Do patients with schizophrenia have a more severe course of COVID-19 illness, as manifested by higher rates of hospitalization and mortality?

Patients with schizophrenia and age-and-sex matched controls (total n = 51,078) were assessed for frequency of COVID-19 positivity, hospitalizations, and mortality. The odds for COVID-19-associated hospitalization and mortality were calculated using logistic regression models, controlling for age, sex, marital status, sector, socioeconomic status, diabetes, ischemic heart disease, hypertension, hyperlipidemia, obesity, smoking, and chronic obstructive pulmonary disease.

The authors found that Individuals with schizophrenia were less likely to test positive for COVID-19. However, they were twice as likely to be hospitalized for COVID-19, even after controlling for sociodemographic and clinical risk factors. Furthermore, they were three times more likely to die from COVID-19, compared to controls.

The authors concluded that they found evidence of associations between schizophrenia and increased COVID-19 morbidity and mortality compared to controls. The results of the study stress the need to focus intervention efforts on modifiable factors that might minimize mortality rates among patients with schizophrenia.

Reference

1. Tzur Bitan D, Krieger I, Kridin K, Komantscher D, Scheinman Y, Weinstein O, Cohen AD, Cicurel AA, Feingold D. COVID-19 prevalence and mortality among schizophrenia patients: A large-scale retrospective cohort study. Schizophr Bull. 2021 Feb 19:sbab012. doi: 10.1093/schbul/sbab012. Epub ahead of print.

Related Posts

Research news /

Regular sleep patterns are more important to health and longevity than spending eight hours in bed

Research news /

Age and antisuicidal effect of lithium

Research news /

Obesity is associated with increased risk for psychiatric disorders

‹ Ralph Waldo Emerson › Short sleepers live under higher homeostatic sleep pressure than long sleepers

Editorials

  • Suicide in combat veterans
  • Navigating ethical dilemmas in genetic testing for Huntington’s Disease
  • Loneliness: Surgeon General Dr. Murthy’s warning
  • Intranasal esketamine ought to be more widely available

Research Papers

  • COVID-19 mortality in Europe and the ’Iron Curtain’ between East and West
  • Examination of depressive signs and symptoms among 803 University students in seven Universities and Colleges. Hungary, Romania, Serbia.
  • Examination of spirituality and the dimensions of spirituality among 803 students in seven different Universities. Hungary, Romania and Serbia.
  • Examination of depressive signs and symptoms among 932 students in eight different secondary schools in Hungary

Research News

  • Regular sleep patterns are more important to health and longevity than spending eight hours in bed
  • Age and antisuicidal effect of lithium
  • Obesity is associated with increased risk for psychiatric disorders
  • The effect of multivitamin supplementation on memory in older adults

Latest News

  • Suicide rates in the United States in 2022
  • Suicide rates in the United States in 2001-2021
  • Leading world experts on suicide. Expertscape, the January 9, 2023, report
  • Best universities in the world

Interviews with eminent psychiatrists

  • Interview with Professor Shih-Ku Lin
  • Interview with Professor Masahito Fushimi
  • Interview with Professor Maurizio Pompili
  • Interview with Professor Marco Sarchiapone

Ten Years Ago

  • Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free individuals with major depression and healthy controls
  • Plasma testosterone levels in bipolar suicide attempters
  • Teaching medical professionals and trainees about suicide prevention
  • Suicidal ideation in depressed patients with or without comorbid posttraumatic stress disorder treated with selective serotonin reuptake inhibitors

Back to Top

  • About
  • Contact
  • Privacy Policy
  • Terms and Conditions
Copyright © 2023 AVCalc LLC. All rights reserved worldwide.